T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment

Therapeutic options for metastatic colorectal cancer (mCRC) are very limited, and the prognosis using combination therapy with a chemotherapeutic drug and a targeted agent, e.g., epidermal growth factor receptor or tyrosine kinase, remains poor. Therefore, mCRC is associated with a poor median overa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Ziwen, Wieder, Thomas, Mauerer, Bernhard, Schäfer, Luisa, Kesselring, Rebecca, Braumüller, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380781/
https://www.ncbi.nlm.nih.gov/pubmed/37511431
http://dx.doi.org/10.3390/ijms241411673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380781/
https://www.ncbi.nlm.nih.gov/pubmed/37511431
http://dx.doi.org/10.3390/ijms241411673

Ejemplares similares